Vancouver, Washington-based AbSci, a protein printing company, has closed $10.4 million in Series D financing. KBI Biopharma and JSR Life Sciences led the round.
Source: Press Release
AbSci nabs $10.4 mln Series D
Vancouver, Washington-based AbSci, a protein printing company, has closed $10.4 million in Series D financing.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: